← Back to Screener
Balchem Corporation (BCPC)
Price$174.45
Favorite Metrics
Price vs S&P 500 (26W)18.52%
Price vs S&P 500 (4W)1.31%
Market Capitalization$5.59B
P/E Ratio (Annual)36.08x
Indicated Dividend Yield (Annual)0.55%
All Metrics
P/CF (Annual)25.80x
Book Value / Share (Quarterly)$39.22
P/TBV (Annual)4.54x
Indicated Dividend (Annual)$0.87
Revenue Growth (3Y)3.25%
Cash Flow / Share (Quarterly)$5.40
Payout Ratio (TTM)18.27%
Price vs S&P 500 (YTD)11.14%
Gross Margin (TTM)35.74%
Net Profit Margin (TTM)14.93%
EPS (TTM)$4.75
10-Day Avg Trading Volume0.17M
EPS Excl Extra (TTM)$4.75
Revenue Growth (5Y)8.07%
EPS (Annual)$4.75
Dividend / Share (Annual)$0.88
ROI (Annual)10.88%
Gross Margin (Annual)35.74%
Net Profit Margin (5Y Avg)12.68%
Cash / Share (Quarterly)$2.33
P/E Basic Excl Extra (TTM)36.08x
Revenue Growth QoQ (YoY)9.84%
EPS Growth (5Y)12.78%
P/E Normalized (Annual)36.08x
ROA (Last FY)9.18%
Revenue Growth TTM (YoY)8.75%
EBITD / Share (TTM)$7.84
ROE (5Y Avg)11.19%
Operating Margin (TTM)20.18%
Cash Flow / Share (Annual)$5.40
P/B Ratio4.44x
P/B Ratio (Quarterly)3.95x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)5.47x
Net Interest Coverage (TTM)19.58x
ROA (TTM)9.32%
EPS Growth QoQ (YoY)18.62%
EV / EBITDA (TTM)22.23x
EPS Incl Extra (Annual)$4.75
Current Ratio (Annual)2.07x
Quick Ratio (Quarterly)1.27x
3-Month Avg Trading Volume0.19M
52-Week Price Return6.34%
EV / Free Cash Flow (Annual)32.81x
P/E Incl Extra (TTM)36.08x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$34.13
P/S Ratio (Annual)5.39x
Asset Turnover (Annual)0.62x
52-Week High$183.90
Operating Margin (5Y Avg)17.60%
EPS Excl Extra (Annual)$4.75
CapEx CAGR (5Y)5.17%
Tangible BV CAGR (5Y)9.14%
26-Week Price Return22.51%
Quick Ratio (Annual)1.27x
13-Week Price Return9.60%
Total Debt / Equity (Annual)0.13x
Current Ratio (Quarterly)2.07x
Enterprise Value$5,678.009
Revenue / Share Growth (5Y)8.00%
Asset Turnover (TTM)0.62x
Book Value / Share Growth (5Y)8.94%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)5.08x
Pretax Margin (Annual)19.19%
Cash / Share (Annual)$2.33
3-Month Return Std Dev22.13%
Gross Margin (5Y Avg)32.79%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)9.44%
EBITDA Interim CAGR (5Y)8.71%
ROE (Last FY)12.31%
Net Interest Coverage (Annual)19.58x
EPS Basic Excl Extra (Annual)$4.75
P/FCF (TTM)32.28x
Receivables Turnover (TTM)7.88x
EV / Free Cash Flow (TTM)32.81x
Total Debt / Equity (Quarterly)0.13x
EPS Incl Extra (TTM)$4.75
Receivables Turnover (Annual)7.88x
ROI (TTM)10.80%
Dividend Growth Rate (5Y)11.12%
P/S Ratio (TTM)5.39x
Pretax Margin (5Y Avg)16.28%
Revenue / Share (Annual)$31.81
Tangible BV / Share (Annual)$34.13
Forward P/E33.99x
Free OCF CAGR (5Y)8.20%
Price vs S&P 500 (52W)-23.49%
P/E Ratio (TTM)36.08x
EPS Growth TTM (YoY)21.00%
Year-to-Date Return13.78%
5-Day Price Return-0.33%
EPS Normalized (Annual)$4.75
ROA (5Y Avg)7.73%
Net Profit Margin (Annual)14.93%
Month-to-Date Return2.96%
Cash Flow / Share (TTM)$4.87
EBITD / Share (Annual)$7.83
EPS Growth (3Y)13.44%
Operating Margin (Annual)20.18%
LT Debt / Equity (Annual)0.13x
P/CF (TTM)25.80x
ROI (5Y Avg)9.15%
P/E Excl Extra (TTM)36.08x
LT Debt / Equity (Quarterly)0.13x
EPS Basic Excl Extra (TTM)$4.75
P/TBV (Quarterly)4.54x
Payout Ratio (Annual)18.27%
P/B Ratio (Annual)3.95x
Dividend / Share (TTM)$0.88
Inventory Turnover (TTM)5.08x
Pretax Margin (TTM)19.19%
Book Value / Share (Annual)$39.22
Price vs S&P 500 (13W)8.92%
Net Margin Growth (5Y)4.43%
Dividend Yield (TTM)0.51%
Beta0.95x
P/FCF (Annual)32.28x
Revenue / Share (TTM)$32.10
ROE (TTM)12.31%
52-Week Low$139.17
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.00
4.00
4.00
4.00
Industry Peers — Chemicals(13)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
BCPCBalchem Corporation | 5.39x | 8.75% | 35.74% | 12.78% | $174.45 |
SOLSSolstice Advanced Materials Inc. Common Stock | 3.24x | 821.04% | 32.17% | — | $79.96 |
PRMPerimeter Solutions, Inc. | 6.21x | 16.38% | 57.46% | — | $27.70 |
CCThe Chemours Company | 0.60x | 0.43% | 15.55% | — | $23.87 |
OLNOlin Corp. | 0.47x | 3.68% | 7.76% | — | $27.98 |
NGVTIngevity Corporation | 2.10x | -12.02% | 38.23% | — | $73.74 |
HUNHuntsman Corporation | 0.42x | -5.85% | 13.21% | — | $13.74 |
FMCFMC Corporation | 0.63x | -18.34% | 37.00% | -5.53% | $17.58 |
IOSPInnospec Inc. | 1.05x | -3.65% | 27.69% | 32.16% | $75.09 |
ECVTEcovyst Inc. | 2.03x | 8.82% | 22.72% | — | $14.41 |
CITRCitroTech Inc. | 199.00x | 55.26% | 23.39% | — | $8.50 |
About
Balchem manufactures specialty performance ingredients using proprietary microencapsulation and chelation technologies. The company operates three business segments—Human Nutrition and Health (its largest), Animal Nutrition and Health, and Specialty Products—offering choline-based nutrients, mineral amino acid chelates, and specialty chemicals to diverse end markets. Balchem generates the majority of its revenue in the United States, with additional international sales.